Rex Medicare Private Limited
About Rex Medicare Private Limited
Data last updated:
Rex Medicare Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2004PTC092535. Its GSTIN is 18AADCR2482H1Z9 (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Biplab Paul and Sima Paul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.73 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹5.65 Lakh (net margin 3.3%) and EBITDA of ₹11.81 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 1% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹39.47 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Rex Medicare has one previous CIN (Corporate Identification Number): U24232AS2004PTC007594. The current CIN is U24232GJ2004PTC092535, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232GJ2004PTC092535 | Current |
| U24232AS2004PTC007594 | Previous |
Contact details
Rex Medicare Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No 601 6th Floor B Block Titanium City Centre Anand Nagar Road, Satellite, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rex Medicare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rex Medicare is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rex Medicare Private Limited, buy the company report.
Financials of Rex Medicare Private Limited
FY 2025 filings availableRex Medicare Private Limited reported revenue of ₹1.73 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 1% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rex Medicare Private Limited, buy the company report.
Board of directors of Rex Medicare Private Limited
Rex Medicare has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biplab Paul | Director | 16 Dec 2004 | 21 Years 10 Months | Current |
| Sima Paul | Director | 16 Dec 2004 | 21 Years 10 Months | Current |
Peer comparison
Rex Medicare Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medicone Formulations Private Limited | ₹1.74 Cr (FY 2024) | 6.0% | New Delhi, Delhi, India | |||
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Rex Medicare Private Limitedthis company | ₹1.73 Cr (FY 2025) | ₹5.65 Lakh | 3.3% | -1.0% | 14 | Ahmedabad, Gujarat, India |
| Aman Formulations Private Limited | ₹1.72 Cr (FY 2025) | -12.0% | Badaun, Uttar Pradesh, India |
To see the full peer comparison of Rex Medicare Private Limited, buy the company report.
Auditor
Rex Medicare Private Limited is audited by SUPRAKAS CHAUDHURI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUPRAKAS CHAUDHURI & ASSOCIATES | FY 2018 | 320030E |
Shareholding
The shareholding of Rex Medicare Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rex Medicare Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jan 2007 | 10169821 | State Bank of India | ₹39.47 Lakh | Open |
To see the full charge records of Rex Medicare Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Rex Medicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rex Medicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rex Medicare Private Limited has a workforce of 14 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Rex Medicare has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AADCR2482H1Z9 | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rex Medicare Private Limited, buy the company report.
Recent activity
Rex Medicare Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Shefali Paul ceased to be Director on 31 May 2011.
Frequently asked questions
Rex Medicare is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2004 (22+ years old) and is registered under CIN U24232GJ2004PTC092535.
Rex Medicare has 2 current directors:
- Biplab Paul - Director
- Sima Paul - Director
The latest financial statements of Rex Medicare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rex Medicare is 18AADCR2482H1Z9, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Rex Medicare is U24232GJ2004PTC092535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rex Medicare was incorporated on 16 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Rex Medicare by revenue are Medicone Formulations Private Limited, Sandmartin Pharmaceuticals Private Limited, Aman Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Shefali Paul ceased to be Director on 31 May 2011. Biplab Paul was appointed as Director on 16 Dec 2004. Sima Paul was appointed as Director on 16 Dec 2004.
The registered office of Rex Medicare is at Office No 601 6th Floor B Block Titanium City Centre Anand Nagar Road, Satellite, Ahmedabad, Gujarat, India – 380015.
Rex Medicare operates in the pharma industry, in the drug formulation and development segment.
Rex Medicare has open charges of ₹39.47 Lakh and no satisfied charges on record as per latest MCA filings.